Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
2(50.0%)
4Total
N/A(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06617884Not ApplicableRecruiting

Home-based Gait and Balance Training in Patients With Movement Disorders

Role: lead

NCT04011254Unknown

Haemodialysis fMRI Salt Appetite Study

Role: collaborator

NCT02270489Phase 1Completed

Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA

Role: collaborator

NCT02976168Not ApplicableCompleted

Intracranial Pressure and Brain Function: Effects of Head Down Tilt Upon Brain Perfusion and Cognitive Performance

Role: collaborator

NCT02267434Phase 1Completed

Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease

Role: collaborator

NCT02729597Completed

Tracking the Brain in Myotonic Dystrophies: a 5-year Longitudinal Follow-up Study

Role: collaborator

All 6 trials loaded